130 related articles for article (PubMed ID: 38701649)
41. Clinical features and prognostic factors of male breast cancer
Sang G; Pan H; Lu C; Sun R; Zha X; Wang S; Zhu D
Transl Cancer Res; 2021 May; 10(5):2199-2209. PubMed ID: 35116538
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the prognosis of medullary breast carcinoma and invasive ductal carcinoma: a SEER-based study.
Chen Y; Xu Z; Chen Y; Dai Y; Ding J
Transl Cancer Res; 2024 Jan; 13(1):231-248. PubMed ID: 38410238
[TBL] [Abstract][Full Text] [Related]
43. Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value.
Lacle MM; van Diest PJ; Goldschmeding R; van der Wall E; Nguyen TQ
PLoS One; 2015; 10(3):e0118957. PubMed ID: 25738829
[TBL] [Abstract][Full Text] [Related]
44. Raman analysis of microcalcifications in male breast cancer.
Caldarone A; Piccotti F; Morasso C; Truffi M; Sottotetti F; Guerra C; Albasini S; Agozzino M; Villani L; Corsi F
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 263():120185. PubMed ID: 34298281
[TBL] [Abstract][Full Text] [Related]
45. Chromosome 17 copy number changes in male breast cancer.
Lacle MM; Moelans CB; Kornegoor R; van der Pol C; Witkamp AJ; van der Wall E; Rueschoff J; Buerger H; van Diest PJ
Cell Oncol (Dordr); 2015 Jun; 38(3):237-45. PubMed ID: 25906114
[TBL] [Abstract][Full Text] [Related]
46. Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.
Biesma HD; Schouten PC; Lacle MM; Sanders J; Brugman W; Kerkhoven R; Mandjes I; van der Groep P; van Diest PJ; Linn SC
Genes Chromosomes Cancer; 2015 Dec; 54(12):734-44. PubMed ID: 26355282
[TBL] [Abstract][Full Text] [Related]
47. Male Breast Cancer and Hyperestrogenemia: A Thirteen-Year Review.
Tariq KB; Al-Saffar F; Ibrahim S; Pham D; Farhangi A; Rana F; Zaiden R
World J Oncol; 2014 Apr; 5(2):55-61. PubMed ID: 29147378
[TBL] [Abstract][Full Text] [Related]
48. Male Breast Cancer: Three Case Reports and a Literature Review.
Xin Y; Wang F; Ren D; Zhao F; Zhao J
Anticancer Agents Med Chem; 2023; 23(19):2161-2169. PubMed ID: 37605409
[TBL] [Abstract][Full Text] [Related]
49. Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma.
Wick MR; Sayadi H; Ritter JH; Hill DA; Reddy VB; Gattuso P
Am J Clin Pathol; 1999 Jan; 111(1):59-69. PubMed ID: 9894455
[TBL] [Abstract][Full Text] [Related]
50. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
51. Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer.
Sun H; Zhang L; Wang Z; Gu D; Zhu M; Cai Y; Li L; Tang J; Huang B; Bosco B; Li N; Wu L; Wu W; Li L; Liang Y; Luo L; Liu Q; Zhu Y; Sun J; Shi L; Xia T; Yang C; Xu Q; Han X; Zhang W; Liu J; Meng D; Shao H; Zheng X; Li S; Pan H; Ke J; Jiang W; Zhang X; Han X; Chu J; An H; Ge J; Pan C; Wang X; Li K; Wang Q; Ding Q
Nat Commun; 2023 Sep; 14(1):5590. PubMed ID: 37696831
[TBL] [Abstract][Full Text] [Related]
52. Computational Biology of BRCA2 in Male Breast Cancer, through Prediction of Probable nsSNPs, and Hit Identification.
Shinde SD; Satpute DP; Behera SK; Kumar D
ACS Omega; 2022 Aug; 7(34):30447-30461. PubMed ID: 36061650
[TBL] [Abstract][Full Text] [Related]
53. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
54. Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
Williams AD; McGreevy CM; Tchou JC; De La Cruz LM
Ann Surg Oncol; 2020 Oct; 27(10):3605-3611. PubMed ID: 32472417
[TBL] [Abstract][Full Text] [Related]
55. Clinical, Pathological, and Prognostic Features of Male Breast Cancer: A Multicenter Study.
Accomasso F; Actis S; Minella C; Rosso R; Granaglia C; Ponzone R; Biglia N; Bounous VE
Curr Oncol; 2023 Nov; 30(11):9860-9871. PubMed ID: 37999136
[TBL] [Abstract][Full Text] [Related]
56. Analysis of the Clinical Advancements for
McClurg DP; Urquhart G; McGoldrick T; Chatterji S; Miedzybrodzka Z; Speirs V; Elsberger B
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804947
[TBL] [Abstract][Full Text] [Related]
57. Frequent amplification and overexpression of CCND1 in male breast cancer.
Bärlund M; Kuukasjärvi T; Syrjäkoski K; Auvinen A; Kallioniemi A
Int J Cancer; 2004 Oct; 111(6):968-71. PubMed ID: 15300811
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
Masci G; Caruso M; Caruso F; Salvini P; Carnaghi C; Giordano L; Miserocchi V; Losurdo A; Zuradelli M; Torrisi R; Di Tommaso L; Tinterri C; Testori A; Garcia-Etienne CA; Gatzemeier W; Santoro A
Oncologist; 2015 Jun; 20(6):586-92. PubMed ID: 25948676
[TBL] [Abstract][Full Text] [Related]
59. Favorable Long-Term Outcome in Male Breast Cancer.
Özkurt E; Tükenmez M; Yılmaz R; Cabioğlu N; Müslümanoğlu M; Dinççağ AS; İğci A; Özmen V
Eur J Breast Health; 2018 Jul; 14(3):180-185. PubMed ID: 30123885
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer.
Leone JP; Hassett MJ; Leone J; Tolaney SM; Vallejo CT; Leone BA; Winer EP; Lin NU
Cancer; 2022 Nov; 128(21):3796-3803. PubMed ID: 36069365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
